Workflow
Editas Medicine (EDIT) Reports Q4 Loss, Misses Revenue Estimates
EDITEditas Medicine(EDIT) ZACKS·2025-03-06 07:25

Editas Medicine (EDIT) came out with a quarterly loss of 0.55pershareversustheZacksConsensusEstimateofalossof0.55 per share versus the Zacks Consensus Estimate of a loss of 0.39. This compares to loss of 0.23pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof41.030.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -41.03%. A quarter ago, it was expected that this genome editing company would post a loss of 0.76 per share when it actually produced a loss of $0.75, delivering a surprise of 1.32%.Over the last four quarters, the compa ...